8 results
Pulmonary Hypertension Algorithm - Matthew Watto, MD
#Diagnosis #Management #Pulmonary #Hypertension #PAH #Workup #Evaluation #Algorithm #Differential #Curbsiders
Pulmonary Hypertension ... Watto, MD #Diagnosis ... #Management #Pulmonary ... #Hypertension #PAH ... #Workup #Evaluation
Diagnostic algorithm for a child or adolescent with suspected pulmonary hypertension. CHD, congenital heart disease; CPET,
Diagnostic algorithm ... congenital heart disease ... #Diagnosis #Peds ... #Hypertension #Workup ... #Algorithm
Diabetic Foot Ulcer - Peripheral Arterial Disease Assessment Algorithm

Early Revascularization vs Conservative Care

Workup:
 • Arterial doppler
Peripheral Arterial Disease ... Assessment Algorithm ... Conservative Care Workup ... #PAD #Diagnosis ... revascularization #podiatry #management
Pulmonary Renal Syndromes - OnePager Summary
Autoimmune ANCA vasculitis (AAV): GPA (granulomatous with polyangiitis), EGPA (eosinophilic granulomatosis
life-threatening diseases ... Inflammatory eye disease ... mononeuritis multiplex WORKUP ... & DIAGNOSIS Labs ... #management #treatment
Upper Lobe Lung Diseases - STAR CHASERS Mnemonic

S - Silicosis
T - Tuberculosis
A - Ankylosing Spondylitis
R -
Upper Lobe Lung ... elimination of CO2 & pH ... Pulmonary Diseases ... Silicosis - Coal worker ... #differential #diagnosis
Algorithm for the Evaluation of Chronic Diarrhea (< 7 days)
Exclude:
1. Causes of acute diarrhea
2. Lactose intolerance
3.
Evaluation of Chronic ... Systemic disease ... Chronic #Diarrhea #management ... #algorithm #workup ... #diagnosis #differential
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
Preoperative Risk Evaluation ... murmur 3/6) - Pulmonary ... event, follow ACC algorithm ... medical and surgical management ... stratification #diagnosis
Myelodysplastic syndromes current treatment algorithm 2018.

From Blood Cancer Journal, Published 24 May 2018

Myelodysplastic syndromes (MDS) are
current treatment algorithm ... risk of clonal evolution ... median age at diagnosis ... cardiovascular or pulmonary ... extensive off-label